ELEVANCE HEALTH INC (ELV) Stock Institutional Trading Activity


ELEVANCE HEALTH INC (ELV) position changes reported by tracked institutional filers across multiple SEC 13F reporting periods. Based on recent SEC 13F filings (Q4 2025), investors with some of the largest reported share count changes include Brave Warrior Advisors, Eagle Capital Management, Baupost Group, Vulcan Value Partners, and Yacktman Asset Management. Explore insights into buying and selling patterns, position changes, and investment conviction levels to understand institutional trading behavior and market dynamics.

Explore more:

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q4 2022Yacktman Asset ManagementBuy1,168386,700$198,365,499
Q4 2022Renaissance Technologies LLCBuy3,200302,073$154,954
Q4 2022Vulcan Value PartnersSell-77,455313,598$160,626
Q4 2022Sequoia Financial AdvisorsBuy1,3114,361$2,237,067
Q4 2022Hancock Classic ValueSell-292191,700$98,336,349
Q4 2022Sequoia FundSell-161,334826,523$423,981,503
Q4 2022Brave Warrior AdvisorsSell-317,456872,415$447,522,723
Q4 2022First Eagle U.S. ValueSell-49,4291,790,501$918,473,298
Q4 2022Viking Global InvestorsSell-464,6651,872,176$960,370,123
Q3 2022Vulcan Value PartnersSell-777,825391,053$177,632
Q3 2022Eagle Capital ManagementSell-33,3601,306,883$593,639
Q3 2022Yacktman Asset ManagementSell-788385,532$175,124
Q3 2022Sequoia Financial AdvisorsSell-6523,050$1,385
Q3 2022Hancock Classic ValueSell-380191,992$87,210
Q3 2022Renaissance Technologies LLCBuy239,200298,873$135,760
Q3 2022Sequoia FundSell-26,130987,857$448,724
Q3 2022Brave Warrior AdvisorsSell-21,4051,189,871$540,487
Q3 2022First Eagle U.S. ValueSell-171,0701,839,930$835,770
Q3 2022Viking Global InvestorsBuy872,3562,336,841$1,061,487
Q2 2022Eagle Capital ManagementSell-1,038,2431,340,243$646,774
Q2 2022Sound Shore ManagementSell-33,912125,137$60,389
Q2 2022Yacktman Asset ManagementSell-257386,320$186,430
Q2 2022Sequoia Financial AdvisorsBuy2823,702$1,787
Q2 2022Renaissance Technologies LLCSell-130,70059,673$28,797
Q2 2022Hancock Classic ValueBuy1,626192,372$92,835
Q2 2022Sequoia FundSell-743,4411,013,987$489,330
Q2 2022Brave Warrior AdvisorsSell-141,9731,211,276$584,538
Q2 2022Viking Global InvestorsBuy1,323,5901,464,485$706,731
Q2 2022First Eagle U.S. ValueSell-17,9852,011,000$970,468
Q1 2022Eagle Capital ManagementSell-79,9542,378,486$1,168,360

Frequently asked questions about ELV activity

  • Which institutional owners are buying ELV?

    Institutional owners buying ELV include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ELV activity?

    "Buy" means an investor increased their reported position in ELV compared to the prior reporting period. This reflects growing exposure to ELEVANCE HEALTH INC (ELV) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ELV increasing?

    Institutional interest in ELV can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.